Compare WDH & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | WDH | BME |
|---|---|---|
| Founded | 2016 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 654.6M | 547.5M |
| IPO Year | 2020 | 2005 |
| Metric | WDH | BME |
|---|---|---|
| Price | $1.74 | $40.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 263.5K | 36.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.60 | N/A |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $34.18 |
| 52 Week High | $2.18 | $42.74 |
| Indicator | WDH | BME |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 42.33 |
| Support Level | $1.67 | $41.41 |
| Resistance Level | $1.90 | $41.72 |
| Average True Range (ATR) | 0.06 | 0.58 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 16.88 | 36.65 |
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.